⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13922074 | 1.00 | — | — | |
| SCHEMBL27782220 | 0.85 | TSHR (0.41) | — | |
| SCHEMBL19257464 | 0.85 | TSHR (0.41) | — | |
| SCHEMBL3656309 | 0.84 | — | — | |
| SCHEMBL5830092 | 0.82 | LMNA (0.50) | — | |
| SCHEMBL4486364 | 0.82 | — | — | |
| SCHEMBL1657440 | 0.81 | — | — | |
| SCHEMBL23630665 | 0.80 | LMNA (0.54) | — | |
| SCHEMBL10935489 | 0.80 | LMNA (0.54) | — | |
| SCHEMBL7030936 | 0.80 | LMNA (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120829401-A | Catalytic oxidation method of n-pentene | 山东京博石油化工有限公司 | 2025-10-24 | — | — | CN | disclosed |
| CN-112041739-B | Liquid crystal light modulation element | 日产化学株式会社 | 2024-06-11 | — | — | CN | disclosed |
| CN-109755470-B | Composition for porous insulating layer, electrode for nonaqueous electrolyte rechargeable battery, and method for producing electrode | 三星SDI株式会社 | 2022-03-18 | — | — | CN | disclosed |
| EP-3781606-A1 | RADIATION CURABLE INKJET INK COMPOSITIONS, PRINTED ARTICLES, AND THERMAL INKJET METHODS OF USING THE SAME | Kao Corporation (JP) | 2021-02-24 | — | — | EP | disclosed |
| EP-3775064-A1 | IN-LINE PRIMER PRINTING METHODS | Kao Corporation (JP) | 2021-02-17 | — | — | EP | disclosed |
| WO-2019204371-A1 | RADIATION CURABLE INKJET INK COMPOSITIONS, PRINTED ARTICLES, AND THERMAL INKJET METHODS OF USING THE SAME | KAO CORPORATION (JP) | 2019-10-24 | — | — | WO | disclosed |
| WO-2019196918-A1 | FIVE-MEMBERED HETEROCYCLO-PYRIMIDINE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 罗欣药业(上海)有限公司 | 2019-10-17 | — | — | WO | disclosed |
| WO-2019195539-A1 | IN-LINE PRIMER PRINTING METHODS | KAO CORPORATION (JP) | 2019-10-10 | — | — | WO | disclosed |
| EP-2844711-A1 | AN INKJET INK COMPOSITION | Domino Printing Sciences PLC (GB) | 2015-03-11 | — | — | EP | disclosed |
| WO-2013164591-A1 | AN INKJET INK COMPOSITION | DOMINO PRINTING SCIENCES PLC (GB) | 2013-11-07 | — | — | WO | disclosed |
| EP-0763053-A4 | STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE | SMITHKLINE BEECHAM CORP (US) | 1998-09-09 | — | — | EP | disclosed |
| US-5760025-A | ADMINISTERING TESTOSTERONE 5A-REDUCTASE INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1998-06-02 | — | — | US | disclosed |
| US-5717088-A | REACTING WITH A CYANOPHOSPHATE IN THE PRESENCE OF AN ALKALI METAL CYANIDE | SANKYO COMPANY, LIMITED (JP) | 1998-02-10 | — | — | US | disclosed |
| US-5698720-A | INTERMEDIATES FOR TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1997-12-16 | — | — | US | disclosed |
| EP-0567271-B1 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO CO (JP) | 1997-07-02 | — | — | EP | disclosed |
| EP-0763053-A1 | STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE | SMITHKLINE BEECHAM CORPORATION (US) | 1997-03-19 | — | — | EP | disclosed |
| EP-0725074-A2 | Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives | SANKYO COMPANY LIMITED (JP) | 1996-08-07 | — | — | EP | disclosed |
| US-5536714-A | Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-16 | — | — | US | disclosed |
| WO-1995033761-A1 | STEROID DERIVATIVES FOR TREATMENT OF 5 ALPHA REDUCTASE | SMITHKLINE BEECHAM CORPORATION (US) | 1995-12-14 | — | — | WO | disclosed |
| EP-0567271-A2 | Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses | SANKYO COMPANY LIMITED (JP) | 1993-10-27 | — | — | EP | disclosed |